OneSource Specialty Pharma Limited (BOM:544292)
India flag India · Delayed Price · Currency is INR
1,621.75
-62.20 (-3.69%)
At close: Jul 31, 2026

BOM:544292 Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23
Revenue
15,43314,21614,4491,719387.14
Revenue Growth
4.29%-1.61%740.43%344.07%-
Gross Profit
10,4939,7699,483867.0650.71
Operating Income
560.49251.291,906-1,566-2,164
Net Income
-486.2-738.03-179.71-3,912-7,998
Earnings Per Share
-4.05-6.44-1.63-94.15-200.87
EPS Growth
-----

Revenue by Geography

Fiscal YearFY 2025FY 2024FY 2023
Period EndingMar '25 Mar '24 Mar '23
India
1,9411,183266.11
Ireland
1,750--
United States of America
5,063--
Rest of The World
5,694536.03-
Total
14,4491,719387.14

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash & Investments
1,0301,0302,105222.6494.74
Total Debt
15,03915,0399,4245,7128,642
Net Cash (Debt)
-14,009-14,009-7,319-5,489-8,547
Net Cash Growth
-----
Net Cash Per Share
-116.73-122.24-66.30-132.12-214.66

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23
Operating Cash Flow
-85.23-678.54-1,072-1,628
Capital Expenditures
--5,691-1,281-637.67-439.95
Free Cash Flow
--5,605-1,960-1,710-2,068
Free Cash Flow Growth
-----

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23
Gross Margin
67.99%68.72%65.63%50.43%13.10%
Operating Margin
3.63%1.77%13.19%-91.09%-558.99%
Pretax Margin
-4.36%-6.47%-4.64%-212.71%-1073.63%
Profit Margin
-3.15%-5.19%-1.24%-227.53%-2066.00%
FCF Margin
--39.43%-13.57%-99.45%-534.07%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23
PS Ratio
12.0311.8813.88--